Chang Bin, Lu Lixia, Zheng Xingzheng, Qin Xuying
Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical School, Fudan University, Shanghai 200032, China; E-mail:
Department of Pathology, Shihezi University School of Medicine, Shihezi 832002, China.
Zhonghua Bing Li Xue Za Zhi. 2015 Dec;44(12):868-73.
To investigate the clinical utility of short tandem repeats(STR) genotyping technique for diagnosis of partial hydatidiform moles (PHM).
Ten cases with the original diagnosis of PHM and six cases diagnosed as "favour PHM" or "abnormal villous, PHM not excluded" were selected for the study. The clinical information and follow-up data were reviewed. Histopathologic features were evaluated along with p57 immunohistochemistry. After DNA extraction from each sample, genotyping was performed by AmpFlSTR(®) Identifiler™ PCR kit to amplify 15 STR polymorphism loci plus the amelogenin gender-determining in a single robust PCR.
The age of patients ranged from 18 to 49 years (mean=29 years, median=29 years). Two villous populations (7/16), irregular villous contour (13/16), at least moderate trophoblastic hyperplasia (2/16), cistern formation (8/16), syncytiotrophoblastic knuckles (14/16), trophoblastic pseudoinclusions (6/16) and nucleated fetal red blood cells (8/16) were presented in these cases. Of the cases in the study, STR genotyping identified 4 monospermic complete hydatidiform moles (MCM), 3 dispermic partial hydatidiform moles (DPM) and 9 hydropic abortions (HA). The misdiagnosis rate was 13/16 only relied on morphology evaluation. Immunostaining of p57 showed 3/4 of MCM were focally positive (<5%-20%+), 1/4 of MCM were diffusely positive (70%+), 3/3 of DPM were diffusely positive (≥50%+), 7/9 of HA were diffusely positive (≥50%+), and 2/9 of HA were focally positive (10%+).
Combination of histomorphologic evaluation and p57 immunostaining is insufficient for a definitive diagnosis of PHM. STR genotyping offers an accurate diagnosis of PHM.
探讨短串联重复序列(STR)基因分型技术在部分性葡萄胎(PHM)诊断中的临床应用价值。
选取10例原诊断为PHM的病例以及6例诊断为“倾向PHM”或“绒毛异常,不能排除PHM”的病例进行研究。回顾其临床资料及随访数据。评估组织病理学特征并进行p57免疫组化检测。从每个样本中提取DNA后,使用AmpFlSTR® Identifiler™ PCR试剂盒进行基因分型,以在一次稳健的PCR中扩增15个STR多态性位点以及牙釉蛋白性别决定基因。
患者年龄范围为18至49岁(平均=29岁,中位数=29岁)。这些病例中出现了两种绒毛群体(7/16)、不规则绒毛轮廓(13/16)、至少中度滋养细胞增生(2/16)、形成池状结构(8/16)、合体滋养细胞结节(14/16)、滋养细胞假包涵体(6/16)和成核胎儿红细胞(8/16)。在本研究的病例中,STR基因分型鉴定出4例单精子完全性葡萄胎(MCM)、3例双精子部分性葡萄胎(DPM)和9例稽留流产(HA)。仅依靠形态学评估时误诊率为13/16。p57免疫染色显示,4例MCM中有3例局灶阳性(<5%-20%+),1/4的MCM弥漫阳性(70%+),3例DPM均弥漫阳性(≥50%+),9例HA中有7例弥漫阳性(≥50%+),2例HA局灶阳性(10%+)。
组织形态学评估和p57免疫染色相结合不足以明确诊断PHM。STR基因分型可准确诊断PHM。